-
Mashup Score: 0
Background: Angiotensin receptor-neprilysin inhibitor (ARNI) prescription in the United States remains suboptimal despite strong evidence for efficacy and value in heart failure with reduced ejection
Source: Circulation: Heart FailureCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Perceived Generational, Geographic, and Sex-Based Differences in Choosing a Career in Advanced Heart Failure - 2 year(s) ago
One’s decision to pursue a career in medicine is multifaceted. Subsequently, the choice of subspecialty can be guided by several factors, such as interest in specific diseases, research focus, income, and other professional opportunities. With the growing prevalence of heart failure and the maturation of mechanical circulatory support, there has been a 200% increase in the number of trainees…
Source: Circulation: Heart FailureCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2A Hunger for Action: The Need to Address the Food Environment in the Evaluation and Management of Heart Failure Patients - 2 year(s) ago
Disparities in cardiovascular disease outcomes are a critical and unresolved clinical and public health challenge. Among persons with heart failure (HF), those from racial/ethnic minority groups and socially disadvantaged communities continue to have the greatest likelihood of complications and adverse outcomes.1,2 The roots of these disparities are complex, multidimensional, and involve numerous…
Source: Circulation: Heart FailureCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 3Gut Microbiota-Generated Phenylacetylglutamine and Heart Failure - 2 year(s) ago
BACKGROUND: The gut microbiota-dependent metabolite phenylacetylgutamine (PAGln) is both associated with atherothrombotic heart disease in humans, and mechanistically linked to cardiovascular disease
Source: Circulation: Heart FailureCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3
Kaushik AmancherlaKaushik Amancherla Correspondence to: Kaushik Amancherla, MD, Instructor in Medicine, Advanced Heart Failure and Transplant Cardiology, Vanderbilt University Medical Center, 2220 Pierce Ave, Nashville, TN 37232. Email E-mail Address: [email protected] https://orcid.org/0000-0003-3379-5834 Division of Cardiovascular Medicine, Vanderbilt University Medical Center‚ Nashville‚ TN….
Source: Circulation: Heart FailureCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 8Gut Microbiota-Generated Phenylacetylglutamine and Heart Failure - 2 year(s) ago
BACKGROUND: The gut microbiota-dependent metabolite phenylacetylgutamine (PAGln) is both associated with atherothrombotic heart disease in humans, and mechanistically linked to cardiovascular disease
Source: Circulation: Heart FailureCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 3The Association of Protein Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction - 2 year(s) ago
BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF) are distinct clinical entities, yet there is scant evidence for association
Source: Circulation: Heart FailureCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Role of Pulmonary Artery Wedge Pressure Saturation During Right Heart Catheterization - 2 year(s) ago
Diagnosis and proper classification of pulmonary hypertension (PH) is challenging. Even when gold-standard right heart catheterizations (RHCs) are performed, PH is often misdiagnosed, resulting in inappropriate and potentially harmful treatment approaches.1 Additionally, the definition of PH has expanded recently, putting even more emphasis on accurate hemodynamic assessment during RHC.2–4 A…
Source: Circulation: Heart FailureCategories: Cardiologists, Latest HeadlinesTweet-
@MaryjaneFarrMD @AndrewJSauer @AHajduczok @Carnicelli_Ant @Brian_Houston12 @msiuba @TheWrightHeart @GregJacksonMD @rachkataria @MUSCCardFellows @jteerlinkmd @DrMarthaGulati @MarkDrazner @JTThibs @MarkDrazner and I may have overlapped when I was @UTSWNews! Here is our @MUSCCardFellows prospective study showing the importance of this simple diagnostic tool! @MichaelCViray1 @Brian_Houston12 @DrNancySweitzer @JamesCFangMD @josephahill https://t.co/8w2XyTdTC3
-
-
Mashup Score: 5Safety and Efficacy of Sacubitril/Valsartan in Patients With a Failing Systemic Right Ventricle: A Prospective Single-Center Study - 2 year(s) ago
BACKGROUND: Sacubitril/valsartan was demonstrated to reduce hospitalization rate and mortality in patients with heart failure with reduced ejection fraction. Data on the effects of sacubitril/valsart
Source: Circulation: Heart FailureCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
BACKGROUND: Algorithmic application of the 2019 Society of Cardiovascular Angiography and Intervention (SCAI) shock stages effectively stratifies mortality risk for patients with cardiogenic shock. H
Source: Circulation: Heart FailureCategories: Cardiology News and Journals, Latest HeadlinesTweet
#GraphicalAbstract by @IkeRChinyere from the #CircHF Digital Strategies team on Clinical and Socioeconomic Determinants of #ARNI Prescription at Hospital Discharge in Patients w/ #HFrEF Full article available: https://t.co/WovNenqvyO #AHAJournals https://t.co/DZ2Bn2Eomk